PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+4.46%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.62B
AUM Growth
-$230M
(-8.1%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-18.35%
Top 10 Holdings %
Top 10 Hldgs %
33.63%
Holding
107
New
21
Increased
20
Reduced
20
Closed
27
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$98.3M |
| 2 |
Biogen
BIIB
|
$81.1M |
| 3 |
DISH
DISH Network Corp.
DISH
|
$62.8M |
| 4 |
Baxter International
BAX
|
$61.3M |
| 5 |
Meta Platforms (Facebook)
META
|
$53.2M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$107M |
| 2 |
Bristol-Myers Squibb
BMY
|
$97.9M |
| 3 |
Apple
AAPL
|
$91.2M |
| 4 |
Lam Research
LRCX
|
$90.7M |
| 5 |
AGN
Allergan plc
AGN
|
$84.2M |
Sector Composition
| 1 | Healthcare | 49.14% |
| 2 | Technology | 11.79% |
| 3 | Communication Services | 5.92% |
| 4 | Energy | 5.06% |
| 5 | Financials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Puma Biotechnology
PBYI
$254M
| $43.8M | 1.32% |
+1,471,879
| New | +$43.8M |
|
|
AERI
27
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $41.2M | 1.24% |
2,341,640
-39,495
| -2% | -$695K |
|
28
Hologic
HOLX
$14.7B
| $40.7M | 1.23% |
1,175,350
+720,862
| +159% | +$24.9M |
|
29
Halliburton
HAL
$19.1B
| $40.4M | 1.22% |
+892,964
| New | +$40.4M |
|
30
Becton Dickinson
BDX
$54.5B
| $39.5M | 1.19% |
239,012
+89,167
| +60% | +$14.8M |
|
31
Palo Alto Networks
PANW
$130B
| $39.4M | 1.19% |
1,927,464
-1,056,108
| -35% | -$21.6M |
|
|
32
Bristol-Myers Squibb
BMY
$95.1B
| $38.2M | 1.15% |
519,722
-1,330,649
| -72% | -$97.9M |
|
33
Universal Health Services
UHS
$11.9B
| $33.5M | 1.01% |
249,510
-291,946
| -54% | -$39.1M |
|
|
BPMC
34
DELISTED
Blueprint Medicines
BPMC
| $33.3M | 1.01% |
1,646,516
+226,005
| +16% | +$4.58M |
|
35
Accuray
ARAY
$168M
| $30M | 0.91% |
5,780,693
-103,525
| -2% | -$537K |
|
36
Devon Energy
DVN
$22.5B
| $27.3M | 0.82% |
+754,242
| New | +$27.3M |
|
|
CLVS
37
DELISTED
Clovis Oncology, Inc.
CLVS
| $27.3M | 0.82% |
1,986,582
+112,198
| +6% | +$1.54M |
|
38
Alibaba
BABA
$312B
| $26.3M | 0.79% |
330,735
+170,639
| +107% | +$13.6M |
|
39
Vulcan Materials
VMC
$38.4B
| $20.8M | 0.63% |
173,008
-320,063
| -65% | -$38.5M |
|
|
ELGX
40
DELISTED
Endologix Inc
ELGX
| $19.4M | 0.59% |
+155,894
| New | +$19.4M |
|
41
Tenet Healthcare
THC
$17B
| $19.1M | 0.58% |
+691,461
| New | +$19.1M |
|
|
RICE
42
DELISTED
Rice Energy Inc.
RICE
| $19.1M | 0.58% |
+865,063
| New | +$19.1M |
|
43
Visa
V
$684B
| $17.5M | 0.53% |
+235,872
| New | +$17.5M |
|
|
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17.1M | 0.52% |
1,028,867
+285,881
| +38% | +$4.74M |
|
|
ZLTQ
45
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $16.5M | 0.5% |
604,342
-293,787
| -33% | -$8.03M |
|
46
Vipshop
VIPS
$8.36B
| $16.3M | 0.49% |
+1,460,749
| New | +$16.3M |
|
47
Molina Healthcare
MOH
$9.2B
| $15.7M | 0.47% |
+315,479
| New | +$15.7M |
|
|
KITE
48
DELISTED
Kite Pharma, Inc.
KITE
| $15.6M | 0.47% |
311,765
-2,000
| -0.6% | -$100K |
|
49
Voyager Therapeutics
VYGR
$207M
| $14.7M | 0.44% |
1,335,671
+442,130
| +49% | +$4.86M |
|
|
SLCA
50
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $13.2M | 0.4% |
+382,341
| New | +$13.2M |
|